DBH rs1611115: Understanding Your Stress Response Variant
The rs1611115 variant is a functional genetic change located in the promoter region of the DBH gene. It is primarily associated with variations in the activity levels of the enzyme dopamine beta-hydroxylase, which plays a key role in the body's stress response system.
What each genotype means
Higher enzyme activity
This genotype is associated with higher levels of plasma dopamine beta-hydroxylase (DBH) activity compared to those carrying the T allele. DBH is the enzyme responsible for converting dopamine into norepinephrine, a key neurotransmitter involved in stress response and mood regulation. If you are taking medications that interact with catecholamine pathways, please discuss your treatment plan with your clinician or pharmacist.
This is the most common genotype in many populations, including those of European ancestry.
Intermediate enzyme activity
This genotype is associated with intermediate levels of plasma dopamine beta-hydroxylase (DBH) activity. Because DBH helps convert dopamine to norepinephrine, this variation may influence how your body manages certain neurotransmitter levels during stress. If you are taking medications that interact with catecholamine pathways, please discuss your treatment plan with your clinician or pharmacist.
This genotype is frequently observed across diverse populations, representing a significant portion of the population alongside the CC genotype.
Lower enzyme activity
This genotype is associated with the lowest levels of plasma dopamine beta-hydroxylase (DBH) activity. Some research suggests that individuals with this genotype may have different responses to psychological stress or may be at a statistically higher risk for certain personality traits related to impulsiveness or adult ADHD. If you are taking medications that interact with catecholamine pathways, please discuss your treatment plan with your clinician or pharmacist.
This genotype is less common, carried by roughly 1 in 5 to 1 in 10 people depending on their ancestral background.
What is rs1611115?
The rs1611115 variant is a single nucleotide polymorphism (SNP) situated approximately 1,000 base pairs upstream of the DBH gene's starting point. Because it sits in the promoter region—the "on-off switch" area of a gene—it influences how much of the DBH protein is produced. Research indicates that this specific variant is a major contributor to the variance in plasma dopamine beta-hydroxylase activity observed across different human populations. By altering the expression of the gene, the T allele is generally associated with lower levels of the enzyme compared to the C allele. This makes rs1611115 a significant focus for researchers studying how genetic differences in neurotransmitter regulation might influence physiological and behavioral responses to environmental stressors.
The Role of the DBH Gene
The DBH gene provides the blueprint for the enzyme dopamine beta-hydroxylase. This enzyme is responsible for a critical chemical conversion in the body: it transforms dopamine into norepinephrine. Both of these substances are neurotransmitters, which are chemical messengers that allow nerve cells to communicate. Norepinephrine is particularly vital for the autonomic nervous system, which manages involuntary functions like heart rate, blood pressure, and the body's reaction to acute stress. When DBH activity is low, the conversion process is less efficient, potentially leading to higher levels of dopamine and lower levels of norepinephrine. Because this system is central to how we process stress, researchers have long investigated whether variations in this gene contribute to differences in temperament, behavioral traits, and susceptibility to various neurological or psychiatric conditions.
Research and Evidence Strength
The evidence linking rs1611115 to specific health outcomes is considered limited and often mixed. While studies have consistently shown that the T allele correlates with lower plasma DBH activity, the leap from enzyme levels to complex behavioral traits is more difficult to prove. Some research has explored associations between this variant and conditions like ADHD, schizophrenia, or neuroticism, but results are frequently inconsistent across different studies. Furthermore, some investigations have suggested that the T allele might offer a protective effect against certain neurodegenerative conditions like Parkinson's disease, though these findings require further validation. It is important to note that complex traits are influenced by a vast array of genetic and environmental factors. Therefore, a single SNP like rs1611115 cannot be used to predict an individual's behavior or health status with certainty.
What You Can Do With This Information
Genetic information regarding variants like rs1611115 is primarily educational and should not be used for medical diagnosis or to make health decisions. Because the associations between this variant and clinical outcomes are not definitive, it is not a reliable tool for predicting personal health risks. If you are concerned about stress, behavioral health, or any symptoms related to your autonomic nervous system, the most effective approach is to consult with a qualified healthcare professional. They can provide a comprehensive evaluation based on your medical history, physical exams, and validated clinical testing. If you are currently taking medications that affect your neurotransmitter levels, always discuss your treatment plan and any questions about dosing with your clinician or pharmacist. Never alter your medication regimen based on genetic test results without professional medical guidance.
How common is this variant?
The T allele is relatively common, with a minor allele frequency of approximately 0.18–0.22 in European populations and 0.08–0.12 in East Asian populations.
Frequently asked questions
Does having the TT genotype mean I have a medical condition?
No. The rs1611115 variant is a common genetic polymorphism and is not a diagnostic marker for any specific disease. It simply influences the activity level of an enzyme in your body.
Can I use this SNP to predict my risk for ADHD?
No. While some studies have explored links between DBH variants and ADHD, the evidence is inconsistent. ADHD is a complex condition influenced by many genes and environmental factors, not a single SNP.
Should I change my diet or supplements based on my DBH genotype?
You should not change your diet or take supplements based on this genetic information. Always consult with a doctor or registered dietitian before making significant changes to your health regimen.
Is this variant related to Parkinson's disease?
Some research has suggested a potential association between the TT genotype and a lower risk of Parkinson's disease. However, these findings are not conclusive and should not be used for personal health forecasting.
Sources & further reading
Educational information only, last refreshed 9/29/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1611115?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29